P3 Health Partners (PIII) | Financial Analysis & Statements
P3 Health Partners Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
384.8M
Operating Income
-153.9M
-39.98%
Net Income
-165.7M
-43.06%
EPS (Diluted)
$-23.02
Balance Sheet Metrics
Total Assets
656.6M
Total Liabilities
796.9M
Shareholders Equity
-140.2M
Cash Flow Metrics
Operating Cash Flow
-133.0M
Free Cash Flow
-25.6M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
P3 Health Partners Income Statement From 2020 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2020 |
|---|---|---|---|---|---|
| Revenue | 1.5B | 1.5B | 1.3B | 1.0B | 491.1M |
| Cost of Goods Sold | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 107.2M | 113.9M | 125.6M | 162.4M | 54.9M |
| Other Operating Expenses | 1.5B | 1.6B | 1.2B | 1.0B | 464.0M |
| Total Operating Expenses | 1.6B | 1.7B | 1.3B | 1.2B | 518.9M |
| Operating Income | -270.3M | -312.6M | -167.9M | -246.0M | -28.6M |
| Operating Margin % | -18.5% | -20.8% | -13.3% | -23.4% | -5.8% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 55.0M | 22.2M | 16.0M | 11.4M | 2.5M |
| Other Non-Operating Income | 4.3M | 28.8M | 184.0K | -1.3B | -290.7K |
| Pre-tax Income | -321.1M | -306.0M | -183.7M | -1.6B | -31.4M |
| Income Tax | 2.0M | 4.4M | 2.7M | 1.9M | 0 |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -323.1M | -310.4M | -186.4M | -1.6B | -31.4M |
| Net Margin % | -22.1% | -20.7% | -14.7% | -148.8% | -6.4% |
| Key Metrics | |||||
| EBITDA | -189.6M | -225.1M | -81.5M | -155.9M | -28.1M |
| EPS (Basic) | $-45.26 | $-47.00 | $-0.61 | $-6.50 | $-0.46 |
| EPS (Diluted) | $-45.26 | $-54.00 | $-0.63 | $-6.50 | $-0.46 |
| Basic Shares Outstanding | 3269000 | 2903500 | 94889000 | 41600000 | 68159532 |
| Diluted Shares Outstanding | 3269000 | 2903500 | 94889000 | 41600000 | 68159532 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
P3 Health Partners Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 25.0M | 38.8M | 36.3M | 17.5M | 140.5M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 92.5M | 121.3M | 118.5M | 72.1M | - |
| Inventory | - | - | - | - | - |
| Other Current Assets | 11.4M | 14.4M | 3.6M | 2.6M | 7.0M |
| Total Current Assets | 133.1M | 184.1M | 166.0M | 100.7M | 199.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.0M | 1.1M | 1.1M | 1.1M | 451.0K |
| Goodwill | 492.4M | 574.4M | 666.7M | 751.0M | 3.5B |
| Intangible Assets | 492.4M | 574.4M | 666.7M | 751.0M | 835.8M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 27.8M | 19.2M | 19.5M | 16.0M | 10.6M |
| Total Non-Current Assets | 523.6M | 599.3M | 695.0M | 775.9M | 2.2B |
| Total Assets | 656.6M | 783.4M | 861.0M | 876.6M | 2.4B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 81.5M | 64.0M | 43.7M | 25.2M | 5.5M |
| Short-term Debt | 45.0M | 65.0M | - | - | 3.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | 353.0K | - | - | - |
| Total Current Liabilities | 545.3M | 496.4M | 299.4M | 241.7M | 198.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 239.8M | 101.2M | 121.9M | 105.9M | 86.3M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 9.3M | 26.0M | 4.9M | 4.8M | 3.5M |
| Total Non-Current Liabilities | 251.6M | 137.5M | 127.9M | 112.2M | 101.2M |
| Total Liabilities | 796.9M | 633.9M | 427.3M | 353.9M | 299.9M |
| Equity | |||||
| Common Stock | 0 | 36.0K | 32.0K | 24.0K | 24.0K |
| Retained Earnings | -651.1M | -503.2M | -367.3M | -309.5M | -39.4M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | -140.2M | 149.5M | 433.7M | 522.7M | 2.1B |
| Key Metrics | |||||
| Total Debt | 284.9M | 166.2M | 121.9M | 105.9M | 89.9M |
| Working Capital | -412.2M | -312.3M | -133.4M | -141.0M | 1.1M |
Balance Sheet Composition
P3 Health Partners Cash Flow Statement From 2020 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -323.1M | -310.4M | -186.4M | -1.6B | -31.4M |
| Depreciation & Amortization | 84.2M | 86.1M | 86.7M | 87.3M | 795.2K |
| Stock-Based Compensation | 5.6M | 5.8M | 6.0M | 19.4M | 447.5K |
| Working Capital Changes | 34.6M | -6.0M | -26.5M | -17.0M | -23.4M |
| Operating Cash Flow | -152.6M | -230.4M | -119.7M | -1.5B | -54.1M |
| Investing Activities | |||||
| Capital Expenditures | 79.0K | 0 | -1.8M | -2.2M | -2.9M |
| Acquisitions | - | - | 0 | -5.5M | -130.0K |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | 129.0K | 14.5M | -1.8M | -7.7M | -3.2M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | -180.0K |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 73.0M | 88.1M | 14.1M | 15.0M | 36.4M |
| Debt Repayment | -1.1M | -31.0M | 0 | -3.6M | -1.5M |
| Financing Cash Flow | 71.7M | 27.3M | 100.3M | 7.8M | 34.8M |
| Free Cash Flow | -91.2M | -110.1M | -77.9M | -128.3M | -27.5M |
| Net Change in Cash | -80.8M | -188.6M | -21.2M | -1.5B | -22.5M |
Cash Flow Trend
P3 Health Partners Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-0.06
Forward P/E
-12.93
Price to Book
-0.06
Price to Sales
0.01
PEG Ratio
0.00
Profitability Ratios
Profit Margin
-10.14%
Operating Margin
-39.99%
Return on Equity
-6,952.57%
Return on Assets
-23.46%
Financial Health
Current Ratio
0.24
Debt to Equity
-2.05
Beta
0.56
Per Share Data
EPS (TTM)
$-45.26
Book Value per Share
$-47.24
Revenue per Share
$446.34
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| PIII | 551.6M | -0.06 | -0.06 | -6,952.57% | -10.14% | -2.05 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Surgery Partners | 1.9B | 2,956.00 | 1.09 | 2.76% | -2.35% | 114.51 |
| Pediatrix Medical | 1.9B | 11.88 | 2.16 | 20.28% | 8.64% | 73.29 |
| Astrana Health | 1.9B | 73.30 | 2.12 | 4.49% | 0.71% | 193.10 |
Financial data is updated regularly. All figures are in the company's reporting currency.






